The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer

BACKGROUND: Previous findings indicated that polymorphism in gene catechol-O-methyltransferase (COMT) had been linked to chemotherapy-related cognitive impairment (CRCI). Nevertheless, the motivation of COMT polymorphisms in regulating cognitive impairment in breast cancer survivors with disparate s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen, Zhang, Qianqian, Cai, Yinlian, Chen, Tingting, Cheng, Huaidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861381/
https://www.ncbi.nlm.nih.gov/pubmed/35211407
http://dx.doi.org/10.3389/fonc.2022.816923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861381/
https://www.ncbi.nlm.nih.gov/pubmed/35211407
http://dx.doi.org/10.3389/fonc.2022.816923

Ejemplares similares